Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...

A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...

Introduction: Short-read amplicon sequencing studies have typically focused on 1-2 variable regions of the 16S rRNA gene. Species-level resolution is limited in these studies, as each variable region ...

Illumina restored its profitability well: Free Cash Flow is reaching elevated levels. However, the placement of ILMN in China's unreliable entity list could have disruptive implications for its ...

If ASHG attendees can count on one thing, it’s PacBio creating a buzz (and throwing a great party). The company has developed a reputation for launching its products with flair, typically accompanied ...

This article is based on a poster originally authored by Dagmara Wanda Lewandowska, PhD, Marc Gasser, PhD, Vanina Haunreiter-Dengler, PhD and Eva Meszaros, PhD, which was presented at ELRIG Drug ...

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. According to the Zacks Consensus Estimate, the company’s third-quarter earnings are ...